Medically frail seniors see benefit of a few extra pounds
If you’re among the ranks of senior citizens diagnosed as medically frail, it might be in your interest to carry a few more pounds, according to two studies led at the University of Washington.
“Frailty” is a medical syndrome characterized by weight and muscle loss, fatigue, slow walking and low levels of physical activity. It affects some, though not all, older adults, and poses a higher risk of death and disability.
“We highlighted a need to re-evaluate the definition of ‘healthy’ weight in people who have been diagnosed with frailty. Nutritional interventions aimed at slowing down or even preventing body fat loss might be important,” said Oleg Zaslavsky, a UW assistant professor of nursing and primary investigator for both studies.
One study, published in the Journal of the American Geriatric Society, involved a longitudinal evaluation of more than 11,000 women ages 65 to 84 with frailty. Among them, women with a BMI of 25-35 kg/m2 had a lower rate of death than those with lower BMIs.
The finding is out of step with the 18-25 kg/m2 BMI defined as optimal by the U.S. Centers for Disease Control and Prevention. The CDC does not adjust its recommended BMI range for people’s age.
The second study, scheduled to be published this summer in the Journal of Nutrition, Health and Aging, examined the bone mineral density of 876 frail older women. Results associated low body fat with increased mortality.
Both studies challenge the conventional medical guidance that less body mass and less fat is healthier.
“Our next projects will examine diet as it relates to body composition for frail women. Should the relationship be confirmed, this might suggest clinically meaningful diet changes for older persons with frailty,” Zaslavsky said.
The studies used data from the Women’s Health Initiative and adjusted for demographics and health behaviors. The Women’s Health Initiative is one of the United States’ most definitive and far-reaching data sets about older women.
The WHI program is funded by the National Heart, Lung and Blood Institute, the National Institutes of Health, and the U.S. Department of Health and Human Services. The funding agencies had no role in the design and conduct of this study, the analysis or interpretation of the data, or the preparation of the manuscript.
In addition to the University of Washington, researchers from the University of Haifa, Israel; Fred Hutchinson Cancer Research Center; the University of California, San Diego; the University of Texas MD Anderson Cancer Center; Wake Forest School of Medicine; the University of Buffalo; and Stanford University contributed to the works.